Therapeutic Effects of Modified Gengnianchun Formula on Stress-Induced Diminished Ovarian Reserve Based on Experimental Approaches and Network Pharmacology [Erratum]
Authors Gao L, Zhang Y, Xu H, Zhao F, Wang W
Received 15 January 2021
Accepted for publication 15 January 2021
Published 27 January 2021 Volume 2021:15 Pages 349—350
Gao L, Zhang Y, Xu H, Zhao F, Wang W. Drug Des Devel Ther. 2020;14:4975–4992
The authors have advised that there was an error in the author list on page 4975 which was introduced by the Editorial staff during the publication process.
The correct author list and affiliations are as follows:
1Department of Integrated Traditional Chinese Medicine and Western Medicine, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, 200011, People’s Republic of China; 2Shanghai Key Laboratory
of Female Reproductive Endocrine Related Diseases, Shanghai 200011, People’s Republic of China; 3Department of Ultrasound Diagnosis, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, 200011, People’s Republic of China
*These authors contributed equally to this work
There was also an error on page 4990. Acknowledgment section, the acknowledgment “Lingyun Gao and Yang Zhang are joint first authors” was not included by Editorial staff.
Read the original article
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]